α-MSH	Alpha-Melanocyte-Stimulating Hormone
AMPA	α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid
AKT	Ak Strain Transforming
AP	Area Postrema
ARC	Arcuate Nucleus
BAT	Brown Adipose Tissue
BBB	Blood–Brain Barrier
cAMP	Cyclic Adenosine Monophosphate
CeA	Central Amygdala
CNS	Central Nervous System
DA	Dopamine
DPP-4	Dipeptidyl Peptidase-4
ERK	Extracellular Signal-Regulated Kinase
GABA	Gamma-Aminobutyric Acid
GCGR	Glucagon Receptor
GIP	Glucose-Dependent Insulinotropic Polypeptide
GIPR	Glucose-Dependent Insulinotropic Polypeptide Receptor
GLP-1	Glucagon-Like Peptide-1
GLP-1RA	Glucagon-Like Peptide-1 Receptor Agonist
GLP-1R	Glucagon-Like Peptide-1 Receptor
GPCR	G Protein-Coupled Receptor
ILC	Infralimbic Cortex
MAPK	Mitogen-Activated Protein Kinase
MC4R	Melanocortin-4 Receptor
mTOR	Mammalian Target of Rapamycin
NAc	Nucleus Accumbens
NE	Norepinephrine
NPY	Neuropeptide Y
NTS	Nucleus Tractus Solitarius
OUD	Opioid Use Disorder
PFC	Prefrontal Cortex
PI3K	Phosphoinositide 3-Kinase
PK/PD	Pharmacokinetics/Pharmacodynamics
PKA	Protein Kinase A
POMC	Pro-opiomelanocortin
PVN	Paraventricular Nucleus
RCT	Randomized Controlled Trial
RT-PCR	Reverse Transcription Polymerase Chain Reaction
sIPSC	Spontaneous Inhibitory Postsynaptic Current
SNS	Sympathetic Nervous System
SUD	Substance Use Disorder
UCP1	Uncoupling Protein 1
VTA	Ventral Tegmental Area